About Sexton Biotechnologies
Sexton Biotechnologies is a Healthcare company based in Indianapolis (United States) founded in 2019 by Monica Wight and Vicky Tran, and was acquired by BioLife Solutions in August 2021. Process and handling solutions for pharmaceutical sectors are developed. Sexton Biotechnologies has raised $5 million across 1 funding round from investors including BioLife Solutions. Sexton Biotechnologies offers products and services including CryoStor, HypoThermosol, and Stemulate hPL. Its focus areas include Life Sciences, Life Sciences Platforms and Tools and Diversified. Its legal entity is BioLife Solutions Inc. Its competitors include Quanterix, Biocare Medical and BioLife Solutions; 2 of its 3 listed competitors have raised funding.
Company details
Sexton Biotechnologies was founded in 2019 in Indianapolis, United States, with a focus on biotechnology for pharmaceutical applications. A portfolio of solutions is provided, including T-Liven PR for enhancing T-cell functions in vitro and in vivo, human platelet lysate, an automated filling system known as AF-500, and cryogenic CellSeal vials. Operations center on process and handling tools for pharma companies and labs.
- Headquarters Indianapolis, United States
- Founders Monica Wight, Vicky Tran
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website sextonbio.com
- Social LinkedIn X Facebook YouTube
- Acquired by BioLife Solutions (Aug 2021)
- Legal Name Biolife Solutions Inc
- Total Equity Funding$5M (USD)
in 1 rounds
- Latest Funding Round$5M (USD), Series A
Oct 2019
- Investors
- Acquired byBioLife Solutions
(Aug 2021)
Products & Services of Sexton Biotechnologies
Sexton Biotechnologies offers a comprehensive portfolio of products and services, including CryoStor, HypoThermosol, and Stemulate hPL.
Media for cryopreservation of biologics at low temperatures.
Solution for hypothermic storage and shipping of cells.
Platelet lysate for improving cell growth in research.
Apps and channels of Sexton Biotechnologies
its YouTube channel BioLife Solutions has 108 subscribers and 12 videos.
Videos from Sexton Biotechnologies
The most watched videos on Sexton Biotechnologies's YouTube channel, BioLife Solutions (108 subscribers). Click a video to play it here.
More on BioLife Solutions.
Funding Insights of Sexton Biotechnologies
Sexton Biotechnologies has successfully raised a total of $5M through 1 strategic funding round. The most recent funding activity was a Series A round of $5 million completed in October 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5M
- Total Rounds 1
- Last Round Series A — $5M
- First Round $5M
(Oct 2019)
All 1 funding rounds of Sexton Biotechnologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2019 | $5M | Series A | – | – | – |
1 investors in total: 1 institutional.
Investors in Sexton Biotechnologies
Sexton Biotechnologies has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include BioLife Solutions.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Tissue hypothermic storage and cryopreservation freeze media are developed. | 1987 | biolifesolutions.com | Bothell, United States |
Investor details for Sexton Biotechnologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Sexton Biotechnologies
2 people are tracked at Sexton Biotechnologies (2 in leadership).
| Name | Role | Group |
|---|---|---|
Monica Wight | Co-Founder | Leadership |
Vicky Tran | Co-Founder | Leadership |
Complete people profiles for Sexton Biotechnologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Sexton Biotechnologies
3 dated milestones of Sexton Biotechnologies across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Sexton Biotechnologies is founded.
- Funding First funding round of $5.0M.
- Exit Acquired by BioLife Solutions.
Competitors of Sexton Biotechnologies
Sexton Biotechnologies has 3 listed competitors in our database, 2 of them funded. They include Quanterix, Biocare Medical and BioLife Solutions.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| quanterix.com | 2007 | Cambridge, United States | $99.5M | 141 | Assay kits for ultra-sensitive biomarker detection are developed. | |
| biocare.net | 1997 | Concord, United States | $85M | 161 | Primary antibodies and instruments for immunohistochemistry are manufactured. | |
| biolifesolutions.com | 1987 | Bothell, United States | 685 | Tissue hypothermic storage and cryopreservation freeze media are developed. |
Detailed competitors of Sexton Biotechnologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Sexton Biotechnologies (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Sexton Biotechnologies
Complete news archive for Sexton Biotechnologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sexton Biotechnologies
Sexton Biotechnologies was founded in 2019.
Sexton Biotechnologies is headquartered in Indianapolis, United States. It is registered at Indianapolis, Indiana, United States.
Sexton Biotechnologies is a funded company, having raised a total of $5M across 1 funding round to date. The company's 1st funding round was a Series A of $5M, raised on Oct 2019.
Sexton Biotechnologies was founded in 2019 in Indianapolis, United States, with a focus on biotechnology for pharmaceutical applications. A portfolio of solutions is provided, including T-Liven PR for enhancing T-cell functions in vitro and in vivo, human platelet lysate, an automated filling system known as AF-500, and cryogenic CellSeal vials. Operations center on process and handling tools for pharma companies and labs.
Sexton Biotechnologies's top competitors include Biocare Medical, Quanterix and BioLife Solutions.
Sexton Biotechnologies offers CryoStor, HypoThermosol, and Stemulate hPL.
Sexton Biotechnologies has 1 investor. Key investors include BioLife Solutions.
Sexton Biotechnologies operates through Biolife Solutions Inc.
Yes. Sexton Biotechnologies was acquired by BioLife Solutions in August 2021.